EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial).

Saved in:
Bibliographic Details
Title: EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial).
Authors: Hennessy MA; Cancer Research @UCC, College of Medicine & Health, University College Cork, Cork, Ireland., Gatsonis C; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA., Jacene H; Dana-Farber/Brigham Cancer Center, Boston, MA, USA., Connolly RM; Cancer Research @UCC, College of Medicine & Health, University College Cork, Cork, Ireland.; Cancer Trials Cork, CUH/UCC Cancer Center, Cork University Hospital, Cork, Ireland., Burnette BL; Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, USA., Stringer-Reasor EM; University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, USA., Romanoff J; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA., Taurone A; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA., O'Sullivan CC; Mayo Clinic, Rochester, MN, USA., Le-Petross HT; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stearns V; John Hopkins University/Sidney Kimmel Cancer Center, Baltimore, MD, USA., Fowler AM; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Tang SC; Louisiana State University Health Sciences Center, New Orleans, LA, USA., Sepulveda KA; Baylor College of Medicine, Houston, TX, USA., DeMichele AM; University of Pennsylvania/Abramson Cancer Center, Philadelphia, PA, USA., Mankoff DA; University of Pennsylvania/Abramson Cancer Center, Philadelphia, PA, USA., Wolff AC; John Hopkins University/Sidney Kimmel Cancer Center, Baltimore, MD, USA.
Source: Future oncology (London, England) [Future Oncol] 2025 Nov; Vol. 21 (26), pp. 3377-3384. Date of Electronic Publication: 2025 Oct 05.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41047708
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hennessy+MA%22">Hennessy MA</searchLink>; Cancer Research @UCC, College of Medicine & Health, University College Cork, Cork, Ireland.<br /><searchLink fieldCode="AU" term="%22Gatsonis+C%22">Gatsonis C</searchLink>; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Jacene+H%22">Jacene H</searchLink>; Dana-Farber/Brigham Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Connolly+RM%22">Connolly RM</searchLink>; Cancer Research @UCC, College of Medicine & Health, University College Cork, Cork, Ireland.; Cancer Trials Cork, CUH/UCC Cancer Center, Cork University Hospital, Cork, Ireland.<br /><searchLink fieldCode="AU" term="%22Burnette+BL%22">Burnette BL</searchLink>; Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Stringer-Reasor+EM%22">Stringer-Reasor EM</searchLink>; University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Romanoff+J%22">Romanoff J</searchLink>; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Taurone+A%22">Taurone A</searchLink>; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22O'Sullivan+CC%22">O'Sullivan CC</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Le-Petross+HT%22">Le-Petross HT</searchLink>; University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Stearns+V%22">Stearns V</searchLink>; John Hopkins University/Sidney Kimmel Cancer Center, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fowler+AM%22">Fowler AM</searchLink>; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Tang+SC%22">Tang SC</searchLink>; Louisiana State University Health Sciences Center, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Sepulveda+KA%22">Sepulveda KA</searchLink>; Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22DeMichele+AM%22">DeMichele AM</searchLink>; University of Pennsylvania/Abramson Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mankoff+DA%22">Mankoff DA</searchLink>; University of Pennsylvania/Abramson Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Wolff+AC%22">Wolff AC</searchLink>; John Hopkins University/Sidney Kimmel Cancer Center, Baltimore, MD, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2025 Nov; Vol. 21 (26), pp. 3377-3384. <i>Date of Electronic Publication: </i>2025 Oct 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41047708
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14796694.2025.2567840
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3377
    Titles:
      – TitleFull: EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hennessy MA
      – PersonEntity:
          Name:
            NameFull: Gatsonis C
      – PersonEntity:
          Name:
            NameFull: Jacene H
      – PersonEntity:
          Name:
            NameFull: Connolly RM
      – PersonEntity:
          Name:
            NameFull: Burnette BL
      – PersonEntity:
          Name:
            NameFull: Stringer-Reasor EM
      – PersonEntity:
          Name:
            NameFull: Romanoff J
      – PersonEntity:
          Name:
            NameFull: Taurone A
      – PersonEntity:
          Name:
            NameFull: O'Sullivan CC
      – PersonEntity:
          Name:
            NameFull: Le-Petross HT
      – PersonEntity:
          Name:
            NameFull: Stearns V
      – PersonEntity:
          Name:
            NameFull: Fowler AM
      – PersonEntity:
          Name:
            NameFull: Tang SC
      – PersonEntity:
          Name:
            NameFull: Sepulveda KA
      – PersonEntity:
          Name:
            NameFull: DeMichele AM
      – PersonEntity:
          Name:
            NameFull: Mankoff DA
      – PersonEntity:
          Name:
            NameFull: Wolff AC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 26
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1